MedPath
NMPA Approval

Ganciclovir for Injection

国药准字H20054642

May 14, 2024

Drug Information

注射用更昔洛韦

注射剂

按C9H13N5O4计算 0.25g

化学药品

May 14, 2024

Company Information

Applicant Company

广东省东莞市石龙镇西湖工业区信息产业园

Manufacturing Company

广东省东莞市石龙镇西湖工业区信息产业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用更昔洛韦 - NMPA 批准文号 | MedPath